Latest filing published 24 Jun 2020 for Unity Biotechnology, Inc., €21k.
Insider track record
No signal scores available.
Dan Marquess: trading record in brief
Dan Marquess is a declared insider of Unity Biotechnology, Inc., with filings sourced from SEC (Form 4). Between 20 June 2019 and 22 June 2020, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 24 June 2020: a share grant of €21k, in Unity Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dan Marquess
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,483 shares@ US$9.67100.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-017555:0
- 24,255 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-009848:0
- 21,075 shares0Common StockSEC:0001567619-19-013884:0
3 of 3 declarations
